Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Oct 30 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 30, 2023, titled "Zydus and Sun Pharma sign licensing agreement for co-marketing of Desidustat, a critical treatment for Chronic Kidney Disease patients in India".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases